Mavrilimumab

Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death.
Read more
€0.00 (tax incl.)
Reference:
HY-P99031
Product Details
HY-P99031

Data sheet

Size
Multiple sizes
Reactivity
c-Fms
Application
COVID-19-immunoregulation
CAS
1085337-57-0

Menu

Settings